Anti-PD-1 antibodies plus lenvatinib in patients with unresectable hepatocellular carcinoma who progressed on lenvatinib: a retrospective cohort study of real-world patients
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.